On May 26, the Food and Drug Administration (FDA) sent warning letters to Free State Oils, Kingdom Harvest, Kahm CBD,…
In March 2020, the U.S. Food and Drug Administration (FDA) recognized the need for more data to address the gaps…
On May 18, the Collaborative for Cannabinoid Science and Safety (CCSS) sent a letter to U.S. Senators Durbin and Braun…
When addressing the Food and Drug Administration’s (FDA) reluctancy to develop new regulations for cannabidiol (CBD), FDA Commissioner Robert Califf…
On September 1, 2021, Aimed Alliance submitted a comment to Senators Schumer, Wyden, and Booker on the Discussion Draft: Cannabis Administration and Opportunity Act…
Policymakers Should Oppose Efforts to Mandate Coverage of Non-FDA-Approved Cannabis Products that Conflict with Federal Laws & Increase Risk of…
On December 23, 2020, Aimed Alliance submitted a comment to the New York Department of Health on a proposed rule…
Join Aimed Alliance for a FREE webinar on December 2, 2020 at 12:00pm ET. Join Aimed Alliance and the Society…
On July 8, the U.S. Food and Drug Administration (FDA) sent a report titled “Sampling Study of the Current Cannabidiol…
Join Aimed Alliance for a FREE webinar on May 28, 2020 from 3:00pm to 4:00 pm ET. This webinar will…